Abstract
Leptomeningeal dissemination of pituitary adenoma is a very rare occurrence. The present report describes the case of a 28 year old man with a nonfunctioning pituitary adenoma which was operated on and irradiated. Eight years later, the patient developed Cushing's syndrome and multiple leptomeningeal masses were revealed by brain CT and MNR. The diagnosis was ACTH-cell adenoma, without malignant histological signs.
The growth fraction of the tumor, detected by means of the immunohistochemical demonstration of proliferating cell nuclear antigen (PCNA), was 5.45% of cells; this figure is higher than that reported for non-recurrent pituitary adenomas.
From a review of the reported cases, the possibility of predicting late malignant behaviour is discussed. The microscopic aspect has no prognostic value, since metastasizing cases are not overtly malignant in a histological or cytological sense. The application of methods aimed at detecting the growth fraction of the tumor may prove useful in the early identification of aggressive pituitary tumors.
Sommario
La disseminazione leptomeningea di un adenoma ipofisario rappresenta un'evenienza estremamente rara. In questo lavoro si presenta il caso di un adenoma ipofisario non secernente, sviluppatosi in un uomo di 28 anni, sottoposto a trattamento chirurgico e radioterapico. Otto anni più tardi il paziente manifestava una sindrome di Cushing; l'indagine neuroradiologica mediante TC e RMN evidenziava la presenza di masse multiple in sede leptomeningea. Veniva posta diagnosi di adenoma a cellule ACTH-positive, privo di segni di malignità istologica.
La frazione di crescita della neoplasia, determinata mediante dimostrazione immunoistochimica dell'antigene nucleare di proliferazione cellulare (PCNA), corrispondeva al 5,45% delle cellule; tale valore risulta più elevato di quello riferito in letteratura per gli adenomi ipofisari non recidivanti.
Viene discussa, in base alla revisione dei casi finora descritti, la possibilità di prevedere l'acquisizione tardiva di un comportamento maligno da parte di un adenoma ipofisario. L'aspetto microscopico non possiede valore prognostico, poiché adenomi metastatizzanti non hanno aspetto istologico francamente maligno. La determinazione della frazione di crescita tumorale può servire a questo scopo.
Similar content being viewed by others
References
Allegranza A., Girlando S., Arrigoni G.L. et al.:Proliferating cell nuclear antigen expression in central nervous system neoplasms. Virchows Arch. A., 419:417–423, 1991.
Asai A., Matsutani M., Funada N., Takakura K.:Malignant growth hormone-secreting pituitary adenoma with hematogenous dural metastasis: case report. Neurosurgery, 22:1091–1094, 1988.
Burger P.C., Scheithauer B.W., Vogel F.S.:Surgical pathology of the Nervous System and its Coverings, 3rd ed., Churchill Livingston, New York, 1991.
Cairns H., Russell D.S.:Intracranial and spinal metastasis in gliomas of the brain. Brain, 54:377–420, 1931.
Cohen D.L., Diengdoh J.V., Thomas D.G.T., Himsworth R.L.:An intracranial metastasis from a PRL secreting pituitary tumour. Clin. Endocrinol., 18:259–264, 1983.
Ebersold M.J., Quast L.M., Laws E.R. Jr. et al.:Long-term results in transsphenoidal removal of non-functioning pituitary adenomas. J. Neurosurg., 64:713–719, 1986.
Epstein J.A., Epstein B.S., Molho L., Zimmermann H.M.:Carcinoma of the pituitary gland with metastases to the spinal cord and roots of the cauda equina. J. Neurosurg., 21:864–853, 1964.
Feiring E.H., Davidoff L.M., Zimmermann H.M.:Primary carcinoma of the pituitary. J. Neuropathol., 12:205–223, 1953.
Fleischer A.S., Reagan T., Ransohoff J.:Primary caricinoma of the pituitary with metastasis to the brain stem. Case report. J. Neurosurg., 36:781–784, 1972.
Gasser R.W., Finkenstedt G., Skrabal F., et al.:Multiple intracranial metastases from a prolacting secreting pituitary tumor. Clin. Endocrinol., 22:17–27, 1985.
Giometto B., Bozza F., Alessio C., Rigobello L., Tavolato B., Scanarini M.:Ki-67 expression in pituitary adenomas. Clin. Neuropathol., 3:153, 1991.
Graf C.J., Blinderman E.E., Terplan K.L.:Pituitary carcinoma in a child with distant metastases. J. Neurosurg., 19:254–259, 1962.
Hall P.A., Levison D.A., Woods A.L., et al.:Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J. Pathol., 162:285–294, 1990.
Hashimoto N., Handa H., Nishi S.:Intracranial and intraspinal dissemination from a growth hormone-secreting pituitary tumor. J. Neurosurg., 64:140–144, 1986.
Horvath E., Kovacs K., Killinger D.W., et al.:Silent corticotropic adenomas of the human pituitary gland. A histologic, immunocytologic, and ultrastructural study. Am. J. Pathol., 98:617–638, 1980.
Hsu D.W., Hakim F., Biller B.M.K., et al.:Significance of proliferating cell nuclear antigen index in predicting pituitary adenoma recurrence. J. Neurosurg., 78:753–761, 1993.
Kamel O.W., LeBrun D.P., Davis R.E., et al. Growth fraction estimation of malignant lynphomas in formalin-fixed paraffin-embedded tissue using anti-PCNA/cyclin 19A2. Correlation with Ki-67 labeling. Am. J. Pathol., 138:1471–1477, 1991.
Knops E., Kiks K., Perneczky A.:Proliferation activity in pituitary adenomas: measurement by monoclonal antibody Ki-67. Neurosurgery, 25:927–930, 1989.
Kuroky M., Tanaka R., Yokoyama M., Shimbo Y., Ikuta F.:Subarachnoid dissemination of a pituitary adenoma. Surg. Neurol., 28:71–76, 1987.
Landolt A.M.:Ultrastructure of human sella tumors: correlation of clinical findings and morphology. Acta. Neurochir. (Suppl), 22:1–7, 1975.
Landolt A.M., Shibata T., Kleihues P.:Growth rate of human pituitary adenomas. J. Neurosurg., 67:803–806, 1987.
Madonick M.J., Rubinstein L.J., Dasco M.R., Ribner H.:Chromophobe adenoma of the pituitary gland with subrachnoid metastases. Neurology, 13:863–840, 1963.
Martin N.A., Hales M., Wilson C.B.:Cerebellar metastasis from a prolactionoma during treatment with bromocriptine. Case report. J. Neurosurg., 55:615–619, 1981.
Morimura T., Kitz K., Budka H.:In situ analysis of cell kinetics in human brain tumors. A comparative immunocytochemical study of S phase cells by a new in vitro bromodeoxiuridine-labeling technique, and of proliferating pool cells by monoclonal antibody Ki-67. Acta. Neuropathol., 77:276–282, 1989.
Nagashima T., Murovic J.A., Hoshino T., Wilson C.B., Dearmond S.J.:The proliferative potential of human pituitary tumors in situ. J. Neurosurg., 34:588–593, 1986.
Newton T.H., Burhenn H.J., Palubinskas A.J.:Primary carcinoma of the pituitary. A.J.R., 87:110–120, 1962.
Nudleman K.L., Choi B., Kusske J.A.:Primary pituitary carcinomal a clinical pathological study. Neurosurgery, 16:90–95, 1985.
Ostertag, Chr., Weitbrecht W.U.:Dedifferentiation and invasive growth of an eosinophil pituitary adenoma. Acta. Neurochir., 40:175, 1978.
Ogilvy K.M., Jakuboswki J.:Intracranial dissemination of pituitary adenomas. J. Neurol. Neurosurg. Psychiatry, 36:199–205, 1973.
Padoan A., Rigobello L., Scanarini M., Zampieri P.:Adenomi ipofisari a comportamento maligno: presentazione di 2 casi: Ricerca Neurochirurgica, 2:261–272, 1988.
Plangger C.A., Twerdy K., Grunert V., Weiser G.:Subarachnoid metastases from a prolactinoma Neurochirurgica, 28:235–237, 1985.
Rauhut F., Clar H.E., Bamberg M., et al.:Diagnostic criteria in pituitary tumor recurrencecombined modality of surgery and radiotheraphy. Acta. Neurochir., 80:73–78, 1986.
Ricoy J., Carrillo R., Garcia J., Bravo G.:Dissemination of pituitary adenomas. Acta. Neurochir., 31:123–130, 1974.
Russell D.S., Rubinstein L.J.:Pathology of Tumours of the Nervous System. 5th ed., Amold, London, 1989.
Sakamoto T., Itoh Y., Fushimi S., Kowada M., Saito M.:Primary pituitary carcinoma with spinal cord metastasis. Case report. Neurol. Med. Chir., 30:763–777, 1990.
Salassa R.M., Kerns T.P., Kernohan J.W., Sprague R.G., MacCarty C.S.:Pituitary tumors in patient with Cushing's syndrome. J. Clin. Endocrinol. Metab., 19:1523–1539, 1959.
Sang H.U., Johnson C.:Metastatic prolactin-secreting pituitary adenoma. Hum. Pathol., 15:94–96, 1984.
Scheithauer B.W., Randall R.V., Laws E.R., Kovacs K.T., Horvath E., Whitaker M.D.:Prolactin cell carcinoma of the pituitary. Clinicopathologic, immunohistochemical and ultrastructural study of a case with cranial and extracranial metastases. Cancer, 55:595–604, 1985.
Scheithauer B.W., Kovacs K.T., Laws E.R., Randall R.V.:Pathology of invasive pituitary tumors with special reference to functional classification. J. Neurosurg., 65:733–744, 1986.
Schiffer D., Chio A., Giordana M.T., Pezzulo T., Vigliani M.C.:Proliferating cell nuclear antigen expression in brain tumors, and its prognostic role in ependymomas: an immunohistochemical study. Acta. Neuropathol., 85:495–502, 1993.
Shibuya M., Saito F., Miwa T., Davis R.L., Wilson C.B., Hoshino T.:Histochemical study of pituitary adenomas with Ki-67 and anti-DNA polymerase alfa monoclonal antibodies, bromodeoxyuridine labeling, and nucleolar organizer regional counts. Acta. Neuropathol., 84:178–183, 1992.
Selman W.R., Laws E.R. Jr., Scheithauer B.W., Carpenter S.M.:The occurrence of dural invasion in pituitary adenomas. J. Neurosurg., 64:402–407, 1986.
Solitaire G.B., Jatlow P.:Adenohypophyseal carcinoma. Case report. J. Neurosurg., 26:624–632, 1967.
Tonner D., Belding P., Moore S.A., Schlechte J.A.:Intracranial dissemination of Acth secreting pituitary neoplasm — A case report and review of the literature. J. Endocrinol. Invest., 15:387–391, 1992.
Wilkelman N.W., Cassel C., Schlesinger B.:Intracranial tumors with extracranial metastases. J. Neuropathol. Exp. Neurol. 11:149–166, 1952.
Zafar M.S., Mellinger R.C., Chason J.L.:Cushing's disease due to pituitary carcinoma. Henry Ford Hosp. Med. J., 32:61, 1984.
Author information
Authors and Affiliations
Additional information
This study was supported by P.F.A.C.R.O., C.N.R., Rome
Rights and permissions
About this article
Cite this article
Giordana, M.T., Cavalla, P., Allegranza, A. et al. Intracranial dissemination of pituitary adenoma. Case report and review of the literature. Ital J Neuro Sci 15, 195–200 (1994). https://doi.org/10.1007/BF02339323
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02339323